PUGLIESE, NICOLA RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 4.508
AS - Asia 3.476
EU - Europa 2.046
SA - Sud America 561
AF - Africa 168
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.768
Nazione #
US - Stati Uniti d'America 4.386
SG - Singapore 1.280
CN - Cina 999
IT - Italia 679
HK - Hong Kong 596
BR - Brasile 467
SE - Svezia 356
DE - Germania 292
VN - Vietnam 170
GB - Regno Unito 138
BG - Bulgaria 111
FR - Francia 91
FI - Finlandia 83
KR - Corea 83
IN - India 70
CA - Canada 68
RU - Federazione Russa 67
CI - Costa d'Avorio 62
AT - Austria 51
TR - Turchia 49
JP - Giappone 45
BD - Bangladesh 42
SN - Senegal 38
AR - Argentina 36
MX - Messico 30
CZ - Repubblica Ceca 29
NL - Olanda 27
PL - Polonia 27
ES - Italia 25
ZA - Sudafrica 20
IQ - Iraq 19
CH - Svizzera 15
EC - Ecuador 14
UA - Ucraina 13
SA - Arabia Saudita 12
UZ - Uzbekistan 12
ID - Indonesia 11
CO - Colombia 10
PK - Pakistan 10
AZ - Azerbaigian 9
JO - Giordania 9
CL - Cile 8
LT - Lituania 8
MA - Marocco 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
TN - Tunisia 7
BE - Belgio 6
ET - Etiopia 6
NP - Nepal 6
PS - Palestinian Territory 6
IL - Israele 5
IR - Iran 5
PH - Filippine 5
UY - Uruguay 5
AU - Australia 4
BB - Barbados 4
BH - Bahrain 4
IE - Irlanda 4
KZ - Kazakistan 4
MY - Malesia 4
NG - Nigeria 4
PT - Portogallo 4
PY - Paraguay 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
DZ - Algeria 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
KE - Kenya 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BJ - Benin 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GY - Guiana 2
JM - Giamaica 2
LK - Sri Lanka 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SO - Somalia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 10.754
Città #
Singapore 700
Ashburn 625
Hong Kong 589
Dallas 551
Santa Clara 426
Shanghai 291
Chandler 247
Fairfield 236
Beijing 180
Pisa 176
Boardman 147
Los Angeles 145
Woodbridge 145
Houston 142
New York 136
Munich 126
Hefei 123
Seattle 114
Wilmington 113
Sofia 110
Florence 102
Cambridge 85
Seoul 83
Lucca 74
Ann Arbor 73
Abidjan 62
Princeton 60
Frankfurt am Main 59
Chicago 56
London 55
Ho Chi Minh City 53
Redondo Beach 47
Turku 45
Lawrence 44
Medford 39
Buffalo 38
Dakar 38
Tokyo 38
Vienna 36
São Paulo 35
Nuremberg 33
Serra 31
Ogden 29
Dong Ket 25
Hanoi 23
Istanbul 23
Hyderabad 22
Livorno 22
Ottawa 22
Salt Lake City 22
Des Moines 19
Düsseldorf 19
Fuzhou 19
Helsinki 19
Warsaw 19
Toronto 18
San Diego 17
Brooklyn 16
Dhaka 16
Nanjing 16
Boulder 15
Lancaster 15
Olomouc 15
Phoenix 15
Rome 15
Stockholm 15
Tampa 15
Chennai 14
Lauterbourg 14
Montreal 14
Denver 13
Lappeenranta 13
Mexico City 13
Rio de Janeiro 13
Amsterdam 12
Belo Horizonte 12
Cascina 12
Johannesburg 12
Poplar 12
San Francisco 12
Brno 11
Quanzhou 11
Tashkent 11
Dearborn 10
Guangzhou 10
Orem 10
Paris 10
Zurich 10
Baku 9
Bremen 9
Carrara 9
Kent 9
Portsmouth 9
Wuhan 9
Amman 8
Atlanta 8
Haiphong 8
Milan 8
Porto Alegre 8
Redwood City 8
Totale 7.330
Nome #
Three-dimensional echographic evaluation of carotid artery disease 226
MicroRNAs distribution in different phenotypes of Aortic Stenosis 202
Critical Limb Ischemia: A Practical Up-To-Date Review 201
The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: a translational imaging approach 189
The assessment of pressure-volume relationship during exercise stress echocardiography predicts left ventricular remodeling and eccentric hypertrophy in patients with chronic heart failure 184
The added value of exercise stress echocardiography in patients with heart failure 183
Incremental prognostic value of a complex left ventricular remodeling classification in asymptomatic for heart failure hypertensive patients 181
Clinical usefulness of cardio-ankle vascular index, local artery carotid stiffness and global longitudinal strain in subjects with cardiovascular risk factors 180
Classification and Prognostic Evaluation of Left Ventricular Remodeling in Patients With Asymptomatic Heart Failure. 179
Prevalence and Prognostic Impact of Metabolic Syndrome in Asymptomatic (Stage A and B Heart Failure) Patients. 171
Translational cardiovascular imaging: A new integrated approach to target myocardial fibrosis turnover in different forms of cardiac remodeling 161
Left ventricular stiffness predicts outcome in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation 160
Growth Differentiation Factor 15 in Severe Aortic Valve Stenosis: Relationship with Left Ventricular Remodeling and Frailty 158
Circulating mitochondrial DNA signature in cardiometabolic patients 157
Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study 157
Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure Patients 156
Review in translational cardiology: Micrornas and myocardial fibrosis in aortic valve stenosis, a deep insight on left ventricular remodeling 152
Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure 149
Prevalence and determinants of left ventricular diastolic dysfunction in obese subjects and the role of left ventricular global longitudinal strain and mass normalized to height 144
Micro‑RNA‑21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot study 141
The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure 127
Incremental value of 3D echocardiography and two-dimensional speckle tracking in the early detection of cardiotoxicity linked to chemotherapy and trastuzumab in patients with HER-2 positive breast cancer 124
Cardiac Reserve and Exercise Capacity: Insights from Combined Cardiopulmonary and Exercise Echocardiography Stress Testing 124
Characterisation of haemodynamic and metabolic abnormalities in the heart failure spectrum: the role of combined cardiopulmonary and exercise echocardiography stress test 122
Echo-derived peak cardiac power output-to-left ventricular mass with cardiopulmonary exercise testing predicts outcome in patients with heart failure and depressed systolic function 121
null 120
Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels 119
Prognostic Role of Sonographic Decongestion in Patients with Acute Heart Failure with Reduced and Preserved Ejection Fraction: A Multicentre Study 117
Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction 117
Growth Differentiation Factor 15 in Severe Aortic Valve Stenosis: Relationship with Left Ventricular Remodeling and Frailty 112
Exercise-induced pulmonary hypertension in HFpEF and HFrEF: Different pathophysiologic mechanism behind similar functional impairment 111
Acute pericarditis in patients receiving coronavirus disease 2019 vaccines: a case series from the community 110
Ventricular-arterial coupling derived from proximal aortic stiffness and aerobic capacity across the heart failure spectrum 107
Novel Techniques, Biomarkers and Molecular Targets to Address Cardiometabolic Diseases 106
Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes 106
Imaging of Congestion in Cardio-renal Syndrome 105
Flow dynamic assessment of native mitral valve, mitral valve repair and mitral valve replacement using vector flow mapping intracardiac flow dynamic in mitral valve regurgitation 104
Arterial Hypertension and Cardiopulmonary Function: The Value of a Combined Cardiopulmonary and Echocardiography Stress Test 102
Ventricular-Arterial Coupling Derived From Proximal Aortic Stiffness and Aerobic Capacity Across the Heart Failure Spectrum 102
Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial 101
Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing 101
Circulating Long Noncoding RNA Signatures Associate With Incident Diabetes in Older Adults: a Prospective Analysis From the VITA Cohort Study 100
Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study 99
The difficult relationship between uric acid and cardiovascular disease 99
Development of a high-throughput liquid chromatography-tandem mass spectrometry platform for the determination of intact natriuretic peptides in human plasma 96
The emerging role of endothelial function in cardiovascular oncology 96
null 95
Breath analysis combined with cardiopulmonary exercise testing and echocardiography for monitoring heart failure patients: the AEOLUS protocol 95
The impact of ventricular-arterial coupling derived from proximal aortic stiffness on aerobic capacity across the heart failure spectrum 94
The relationship between telomere length and putative markers of vascular ageing: A Systematic Review and Meta-analysis 94
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 92
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome 91
Cardiometabolic Phenotyping in Heart Failure: Differences between Patients with Reduced vs. Preserved Ejection Fraction 88
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 86
Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing 84
Combining cardiopulmonary exercise testing with echocardiography: a multiparametric approach to the cardiovascular and cardiopulmonary systems 83
Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function 82
Distinct effects of type 2 diabetes and obesity on cardiopulmonary performance 81
Circadian heart rate fluctuations predict cardiovascular and all-cause mortality in type 2 and type 1 diabetes: a 21-year retrospective longitudinal study 81
Train the brain to preserve the heart: the link between education and heart failure 80
Transthoracic and transoesophageal echocardiography for tricuspid transcatheter edge-to-edge repair: a step-by-step protocol 79
Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy 79
Haemodynamic and metabolic phenotyping of patients with aortic stenosis and preserved ejection fraction: a specific phenotype of heart failure with preserved ejection fraction? 78
Bio-Humoral and Non-Invasive Haemodynamic Correlates of Renal Venous Flow Patterns across the Heart Failure Spectrum 78
Diagnostic and Prognostic Value of Lung Ultrasound B-Lines in Acute Heart Failure With Concomitant Pneumonia 78
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk 78
mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis 78
Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease 77
Microvascular Ageing Links Metabolic Disease to Age-Related Disorders: The Role of Oxidative Stress and Inflammation in Promoting Microvascular Dysfunction 76
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 71
Characterization of hemodynamic and metabolic abnormalities in the heart failure spectrum the role of combined cardiopulmonary and exercise echocardiography stress test 70
Renal denervation for the treatment of refractory hypertension: where are we? 69
Myocardial fibrosis and microRNA-21 expression in patients with severe aortic valve stenosis and preserved ejection fraction: a 2D speckle tracking echocardiography, tissutal and plasmatic study 68
Decoding the Challenges: navigating Intact Peptide Mass Spectrometry-Based Analysis for Biological Applications 67
The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure 67
Measurement of myocardial amyloid deposition in systemic amyloidosis: Insights from cardiovascular magnetic resonance imaging 65
Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial 65
Microvascular Inflammation and Cardiovascular Prevention: The Role of Microcirculation as Earlier Determinant of Cardiovascular Risk 65
Myocardial signal intensity decay after gadolinium injection: A fast and effective method for the diagnosis of cardiac amyloidosis 64
Integrative assessment of congestion in heart failure using ultrasound imaging 64
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 63
Impact of diabetes on cardiopulmonary function: the added value of a combined cardiopulmonary and echocardiography stress test 63
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 63
Associations of iron deficiency with cardiac function, congestion, exercise capacity and prognosis in heart failure 63
INDEPENDENT EFFECTS OF TYPE 2 DIABETES AND OBESITY ON CARDIOPULMONARY PERFORMANCE IN SUBJECTS AT HIGH CARDIOVASCULAR RISK 63
Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study 62
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation 62
Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions 61
Estimation of Aortic Stiffness with Bramwell-Hill Equation: A Comparative Analysis with Carotid-Femoral Pulse Wave Velocity 60
Low-dose aspirin therapy for primary prevention of cardiovascular disease: where are we at? 59
mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis 59
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 58
Prognostic implication of lung ultrasound in heart failure: a pooled analysis of international cohorts 57
P446 INDEPENDENT EFFECTS OF TYPE 2 DIABETES AND OBESITY ON CARDIOPULMONARY PERFORMANCE IN SUBJECTS AT HIGH CARDIOVASCULAR RISK 57
Exercise echocardiography of left ventricular diastolic function in healthy subjects Insights from the RIGHT-NET 56
Prognostic value of lung ultrasound in patients hospitalized for heart disease irrespective of symptoms and ejection fraction 55
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 54
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 54
Type 2 diabetes and reduced exercise tolerance: A review of the literature through an integrated physiology approach 54
Haemodynamic and metabolic phenotyping of hypertensive patients with and without heart failure by combining cardiopulmonary and echocardiographic stress test 53
Totale 10.117
Categoria #
all - tutte 36.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021184 0 0 0 0 0 15 5 14 33 28 34 55
2021/2022597 7 2 19 40 128 68 20 25 45 29 53 161
2022/2023996 119 157 64 65 64 108 25 84 192 10 97 11
2023/2024873 10 42 102 150 112 99 80 15 9 33 87 134
2024/20253.889 93 119 98 185 277 488 347 154 304 423 518 883
2025/20263.343 407 684 662 619 635 336 0 0 0 0 0 0
Totale 11.126